CASE REPORT
Always expect the unexpected: cystic mediastinal lymphangioma in infants – case report and review
of the literature
More details
Hide details
1
The Student Scientific Society, Poznan University of Medical Sciences, Poland
2
Department of Paediatric Oncology, Haematology, and Transplantology, Institute of Paediatrics, Poznan University of Medical Sciences, Poland
3
Department of Paediatric Radiology, Institute of Paediatrics, Poznan University of Medical Sciences, Poland
4
Department of Pulmonology, Paediatric Allergy and Clinical Immunology, Institute of Paediatrics, Poznan University of Medical Sciences, Poland
5
Department of Paediatric Surgery, Traumatology, and Urology, Institute of Paediatrics, Poznan University of Medical Sciences, Poland
6
Department of Paediatric Bone Marrow Transplantation, Oncology, and Haematology, Medical University, Wroclaw, Poland
7
Department of Paediatrics and Nephrology, Regional Hospital, Miedzyrzecz, Poland
Submission date: 2025-04-07
Final revision date: 2025-06-16
Acceptance date: 2025-07-12
Publication date: 2025-09-24
Corresponding author
Olga Zając-Spychała
Olga Zając-Spychała, Department of Pediatric Oncology, Haematology, and Transplantology, Institute of Paediatrics, Poznań University of Medical Sciences, 27/33 Szpitalna St., 60-572 Poznan, Poland
Pediatr Pol 2025;61(3):271-275
KEYWORDS
TOPICS
ABSTRACT
In the paediatric population, mediastinal tumours occur quite often. They include a variety of entities, with different aetiologies. The most common tumours localised in the anterior mediastinum include thymoma, lymphoma, and teratoma. Herein we present the case of an 8-month-old female infant diagnosed with a huge mediastinal solid-cystic tumour causing superior vena cava syndrome. Ultrasonography-guided needle aspiration was performed. The aspirated fluid contained no epithelial cells but many lymphocytes and neutrophils, based on a cytological analysis. The culture of the material revealed Staphylococcus aureus MRSA. In accordance with the antibiogram, the vancomycin therapy was continued. The antibiotic treatment was continued for 6 weeks achieving complete remission of the lymphangioma, which had lasted for one year.
REFERENCES (14)
1.
Salehi F, Landis M, Inculet R, Wiseman D. Case report of a rare cystic mediastinal lymphangioma mimicking recurrent pleural effusion. Case Rep Radiol 2019; 2019: 1301845. DOI: 10.1155/2019/1301845.
2.
Jeung MY, Gasser B, Gangi A, et al. Imaging of cystic masses of the mediastinum. Radiographics 2002; 22 Spec No: S79-93. DOI: 10.1148/radiographics.22.suppl_1.g02oc09s79.
3.
Teramoto K, Suzumura Y. Mediastinal cavernous lymphangioma in an adult. Gen Thorac Cardiovasc Surg 2008; 56: 88-90.
4.
Fasching G, Dollinger C, Spendel S, Tepeneu NF. Treatment of lymphangiomas by means of sclerotherapy with OK-432 (Picibanil®) is safe and effective – a retrospective case series. Ann Med Surg (Lond) 2022; 81: 104531. DOI: 10.1016/j.amsu.2022.104531.
5.
Bender B, Murthy V, Chamberlain RS. The changing management of chylothorax in the modern era. Eur J Cardiothorac Surg 2016; 49: 18-24.
6.
Jusufovic EM, Keser D, Zukic E. Mediastinal lymphangioma and generalized lymphangiomatosis a case report. Centr Eur J Med 2011; 6: 289-293.
7.
Liu X, Cheng C, Chen K, et al. Recent progress in lymphangioma. Front Pediatr 2021; 9: 735832. DOI: 10.3389/fped.2021.735832.
8.
Park JG, Aubry MC, Godfrey JA, Midthun DE. Mediastinal lymphangioma: Mayo Clinic experience of 25 cases. Mayo Clin Proc 2006; 81: 1197-1203.
9.
Dubois J, Thomas-Chaussé F, Soulez G. Common (cystic) lymphatic malformations: current knowledge and management. Tech Vasc Interv Radiol 2019; 22: 100631. DOI: 10.1016/j.tvir.2019.100631.
10.
Perkins JA, Manning SC, Tempero RM, et al. Lymphatic malformations: review of current treatment. Otolaryngol Head Neck Surg 2010; 142: 795-803, 803.e1. DOI: 10.1016/j.otohns.2010.02.026.
11.
Kennedy TL, Whitaker M, Pellitteri P, Wood WE. Cystic hygroma/lymphangioma: a rational approach to management. Laryngoscope 2001; 111(11 Pt 1): 1929-1937.
12.
Colbert SD, Seager L, Haider F, et al. Lymphatic malformations of the head and neck-current concepts in management. Br J Oral Maxillofac Surg 2013; 51: 98-102.
13.
Luzzatto C, Midrio P, Tchaprassian Z, Guglielmi M. Sclerosing treatment of lymphangiomas with OK-432. Arch Dis Child 2000; 82: 316-318.
14.
Sun J, Wang C, Song D, et al. Efficacy of OK-432 sclerotherapy for different types of lymphangiomas: a review and meta-analysis. Braz J Otorhinolaryngol 2023; 89: 101270. doi: 10.1016/j.bjorl.2023. 03.007.